Olympus Korea said it appointed Tamai Takeshi as its managing director, marking a strategic leadership change to accelerate the company’s continued growth in the Korean medical device market.
Takeshi, a seasoned executive with extensive experience in the medical technology sector, joined Olympus Korea in 2004 as the marketing manager of the medical business. He went on to lead the division as its general manager in 2012 before being promoted to deputy managing director of Olympus Korea in 2024.
Over the past two decades, Takeshi has played a key role in driving Olympus Korea’s business development, leveraging his in-depth understanding of the Korean market. His leadership extended beyond Korea, contributing to Olympus’s broader growth across Asia, particularly in the medical endoscopy business.
In 2011, Takeshi served as senior manager of the corporate innovation office at Olympus Group, overseeing corporate improvement initiatives. He demonstrated his leadership capabilities as vice president of the Gastrointestinal and Respiratory Business Unit in the Asia-Pacific region in 2017, significantly expanding sales and market share.
In his new role, Takeshi is expected to lead Olympus Korea’s efforts to enhance patient safety and quality while continuing to strengthen the company’s presence in Korea. According to Olympus Korea, he also plans to expand value-driven medical solutions tailored to local healthcare professionals and patients.
“Olympus Korea is at the forefront of fostering a patient-centric medical environment through cutting-edge medical technology,” Takeshi said. “We will continue to build trust with local medical professionals and patients, aiming for sustainable growth and contributing to the advancement of Korea’s healthcare industry.”
Olympus Korea, the Korean offshoot of global MedTech leader Olympus Corp., provides diagnostic and therapeutic solutions, including endoscopy systems, laparoscopic devices, and surgical instruments. The company has actively contributed to developing Korea’s medical industry by offering clinically proven and safe technologies.
In 2017, Olympus Korea invested about 37 billion won ($25.1 million) to establish the Korea Training & Education Center (KTEC) in Songdo, Incheon. The center offers healthcare professionals hands-on training and product demonstrations, reflecting Olympus’s ongoing commitment to enhancing public health.